載入...
Achievement of glycaemic control is associated with improvements in lipid profile with iGlarLixi versus iGlar: A post hoc analysis of the LixiLan‐L trial
Diabetic dyslipidaemia is a major risk factor for accelerated atherosclerosis. Glycaemic treatments that improve dyslipidaemia may help reduce the burden of atherosclerosis. This analysis investigated the effect of iGlarLixi [insulin glargine U100 (iGlar) and lixisenatide] versus iGlar on lipid prof...
Na minha lista:
| 發表在: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Blackwell Publishing Ltd
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899526/ https://ncbi.nlm.nih.gov/pubmed/31423722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13857 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|